Viewing Study NCT06980506

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 4:01 PM
Ignite Modification Date: 2026-06-16 @ 4:02 PM
Study NCT ID: NCT06980506
Status: AVAILABLE
Last Update Posted: 2025-05-22
First Post: 2025-05-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: MNPR-101-DFO*-89Zr Expanded Access Program (EAP) for Patients With Solid Tumor Cancer
Sponsor: Monopar Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
None Solid Tumor View
None Solid Tumor, Adult View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Solid Tumor View
None PET/CT View
None urokinase plasminogen activator receptor View
None uPAR View
None Zirconium-89 imaging View
None Positron emission tomography/computed tomography View
None MNPR-101-DFO*-89Zr View
None uPAR-positive View
None Urokinase plasminogen activator receptor-positive View
None EAP IST-00Cb View
None Antibody radionuclide conjugate View
None Monoclonal antibody radionuclide conjugate View
None Solid tumor imaging View